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"QUALITY OF LIFE": AUTOMATIC CARDIOVERTER 
DEFIBRILLATOR VERSUS DRUG THERAPY IN PATIENTS 
WITH MALIGNANT VENTRICULAR ARRHYTHMIAS 
Denise JZtnOsik, Robert Redd, 
Thomas Buck&ham, Roxanne Mikesch, Lawrence 
McBride, St. Louis University, St. Louis MO 
The automatic cardioverter defibrillator (ACD) 
is superior to drug therapy (D) in preventing 
arrhythmic death. However, the impact of the ACD 
compared t0 D on “quality Of life" (0) is 
unknown. W8 compared the responses to the 
Sickness Impact Profile (SIP) a mean of 15 + 12 
months after initiation of electrophysiologic 
auided treatment for ventricular arrhythmias in 
i?pts treated with ACD alone, 30 pts treated 
with D alone, and 17 Patients treated with ACD 
and D. SIP 
to 
candardized 
Q. The higher 
qusstionnrsire 
the numerical, 
AC8 9.5 f 9.2 5.2 5 5.4 10.5 2 8.7 
12.8 + 16.5 7. &, 9.1 12.5 + 11.2 
12.7 f 14.1 
Conclusion: IR ptta with malignant ventricular 
arrhythmias, the impact of illness on Q is 
similar in pts treated with ACD and D. ACD 
treated pts do not appear to experience any more 
psychosocial problems then D treated pts. 
11:M 
TRANSIENT ELECTRICAL STORM: PROGNOSTIC SIGNIFICANCE 
VERY NUMEROUS AUTOMATIC DEFIBRILLATOR DISCHARGES 
OF 
Susan O’Donoghue, Edward V. Platia, Sandra Waclawski, 
Luis Mlspireta, Washington Hospital Center, Washington, DC 
The occurrence of very frequent defibrillator dis- 
charges might be expected to herald a poor prognosis, or 
subaequent persistent rhythm instabiblty. We identified a 
group of 12 patients (pts), from a total of 130 pts with 
automatic implancable dcfibrillators (AICD) and coronary 
artery diGeAse, who have experienced an episode of $0 
appropriate AICD discharges within 48 hours, without as- 
sociated acute myocerdial infarction. The group includes 
9 mm and 3 women, average age 65 years. The episode of 
very numerous discharges occurred 7.2h9.4 (range .25-28) 
months following AICD implanta*‘on. Pts experienced 2% 
18 discharges (range 10 to 59) uuring a 48 hour period. 
Prior to that period, the frequency of discharges had 
been 1~2 per month. Eleven pts had a subsequent change in 
antiarrhythmic drug therapy, and one had a change in drug 
therapy for congestive heart failure. One pt also had re- 
programming of an antitachycardfa pacemaker. With a fol- 
lowup of 22213 months since that time, no pt has died or 
experienced myOCArdiA1 infarction. One pt was hospital- 
ized for unstable angina 12 mo after the episode, and 2 
for congestive heart failure 4 and 12 mo after the epi- 
sode. One pt had been awaiting heart transplantation 
since the time of AICD implantation, and has since re- 
ceived a transplant. The frequency of AICD discharges 
since the episode has been 0.2ZO.3 per month. 
We conclude that an episode of extreme rhythm insta- 
bility fn pts with an AICD And coronary artery disease 
may reflect transient “electrical storm”, and is not nec- 
essarily a harbinger of poor prognosis, Empiric changes 
in antiarrhythmic therapy may br? useful in restoring a 
relatively stable rhythm. 
I1:45 
INCIDENCE OF ANTIARRHYTHMIC DRUS USE IN AICD PATI 
WITH HIGH DEFIBRILLATION THRESHOLDS 
0 Neal Kay, Sharon Dailey, Vance Plumb, ~8nneth 
Eltenboaen. An&a Thomas, David Cannom, Peter Chapman, Debra 
Echt, &herd Fogoros, John Hummel, Joseph L$vine, James 
Maloney, Gerald Naccarelli, and Enrico Veltrl. The University of 
Alabama at Birmingham, Birmingham, AL. 
To characterize patients (pts) with high da~brillatio~ thresholds 
(DFTs) at automatic Implantable oardioverter-defibrillator (AICD) 
implantation, !% pts from 12 centers with DFTs r25J were reviewed. 
The mean age wac 60.3* 10.4 years, 54 were male, 41 had ischemic 
heart disease, 11 n~Mfzhernic cardiomyopathy, 3 valvular heart 
disease, and 1 
voluntary registry, AADs were used in 5,115 (37.436, psO.001) and A in 
2,901 (20.5%, p&.001). By 26$23 months, 25 (55%) pts received 
shocks (19 appropriate) and 9 pts died F, 1 perioperatiwe, 1 
arrest, 1 suddenly, and 1 cause unknown) : AADs, especially A, 
are associated with high DFTs and should used with caution in pts 
treated with AICD therapy. 
10:30 
SBlSMOCARDlOORAPHY FOR MEASUREUENT OF LEFT VENMUCULAR 
PBRWRMANCEATRESTANDIMMEDIATELYPOST~C&E. 
Richard Crow MD, David M. Salerno MD PhD PACC, Reter Hannan MStnt, 
Jabn M. Zanetti MS Univ. Mirwsotr Hennepio County Medical Cemer. 
telaed (0 t~nlikcucmecbanicaisymck, kft-ventricular ejeuim iimeQ.VET), 
psejecth period(PEP), PEP/LVET, amplitudes of mpid diastolic fillin and 
atriat systok. We pnscnr UK following subset of mt pod exercise tie km 
cardiac synole pod diasrole. 
Tasal sysrok(ms) 424 15) NA 424(21) 4lQ23) 
LVCjMtiontime(!ns) 317(13) NA 322(11) 324(14) 
Reepction pnodtm.9) 108(12) NA 102(11) loo(14) 
PEP/LvBT .34(.09) NA .32(.05) .3l(.o!-J) 
NA 
NA 
NA .07(.06) .06(.05) 
NA .06(.04j .06:.04j 
These data agree well with literatum systolic values t 
a simple. aon-invssive metbcd to record systolic 
immediate Past exercise. T&se data provi 
$z;eat and exercise left ventricular functi~l by 
ms= miUiseco5ds 
( ! = stmdmd deviation 
NA = no( evsil&k 
g’s = forw of gravity 
